pubmed-article:12124835 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12124835 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
pubmed-article:12124835 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:12124835 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
pubmed-article:12124835 | lifeskim:mentions | umls-concept:C0005527 | lld:lifeskim |
pubmed-article:12124835 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
pubmed-article:12124835 | lifeskim:mentions | umls-concept:C0078257 | lld:lifeskim |
pubmed-article:12124835 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
pubmed-article:12124835 | lifeskim:mentions | umls-concept:C0205216 | lld:lifeskim |
pubmed-article:12124835 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:12124835 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:12124835 | lifeskim:mentions | umls-concept:C1704419 | lld:lifeskim |
pubmed-article:12124835 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:12124835 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:12124835 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:12124835 | pubmed:dateCreated | 2002-7-18 | lld:pubmed |
pubmed-article:12124835 | pubmed:abstractText | Gemcitabine and vinorelbine are two of the most active third-generation agents for the treatment of advanced nonsmall cell lung carcinoma (NSCLC). The authors conducted a formal Phase II trial to evaluate the efficacy of this combination in both untreated and previously treated patients with Stage IIIB (with pleural effusion) or Stage IV NSCLC. | lld:pubmed |
pubmed-article:12124835 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12124835 | pubmed:language | eng | lld:pubmed |
pubmed-article:12124835 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12124835 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:12124835 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12124835 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12124835 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12124835 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12124835 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12124835 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12124835 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12124835 | pubmed:month | Jul | lld:pubmed |
pubmed-article:12124835 | pubmed:issn | 0008-543X | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:BooksC ACA | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:ShinDong MDM | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:GlissonBonnie... | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:KhuriFadlo... | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:LeeJ JackJJ | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:HongWaun KiWK | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:LiuDiane DDD | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:KiesMerrill... | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:HerbstRoy SRS | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:KurieJonathan... | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:MundenReginal... | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:FossellaFrank... | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:LuCharlesC | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:PistersKather... | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:Papadimitrako... | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:BlumenscheinG... | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:ZinnerRalphR | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:JungMaria SMS | lld:pubmed |
pubmed-article:12124835 | pubmed:author | pubmed-author:LuRobertR | lld:pubmed |
pubmed-article:12124835 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12124835 | pubmed:day | 15 | lld:pubmed |
pubmed-article:12124835 | pubmed:volume | 95 | lld:pubmed |
pubmed-article:12124835 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12124835 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12124835 | pubmed:pagination | 340-53 | lld:pubmed |
pubmed-article:12124835 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:meshHeading | pubmed-meshheading:12124835... | lld:pubmed |
pubmed-article:12124835 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12124835 | pubmed:articleTitle | The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy. | lld:pubmed |
pubmed-article:12124835 | pubmed:affiliation | Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-4009, USA. rherbst@mdanderson.org | lld:pubmed |
pubmed-article:12124835 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12124835 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:12124835 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:12124835 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12124835 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12124835 | lld:pubmed |